image
GlycoMimetics, Inc. GLYC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.416
4.16 %
$ 26.8 M
Market Cap
-0.69
P/E
INCOME STATEMENT
10 K REVENUE
-86.65%
Growth Rates
1Year -86.65%
3Years -90.05%
5Years 0.00%
7Years -8.05%
10Years -45.06%
-39.3 M OPERATING INCOME
17.15%
Growth Rates
1Year 17.15%
3Years 8.64%
5Years 5.28%
7Years -3.01%
10Years -14.01%
-36.9 M NET INCOME
20.97%
Growth Rates
1Year 20.97%
3Years 10.24%
5Years 5.23%
7Years -2.14%
10Years -13.28%
EFFICIENCY
Earnings Waterfall GlycoMimetics, Inc.
image
Revenue 10 K
Cost Of Revenue 153 K
Gross Profit -143 K
Operating Expenses 39.3 M
Operating Income -39.3 M
Other Expenses -2.38 M
Net Income -36.9 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011
REVENUE
Revenue 10 K 74.9 K 1.2 10.2 0 0 0 18 K 20.1 15.0 4.0 15.3 3.8
GROSS PROFIT
Cost Of Revenue 0.2 1.0 1.0 0 0.9 0.3 0.3 0 0 0 0 0 0
Gross Profit (0.1) (1.0) 0.1 10.2 (0.9) (0.3) (0.3) 18 K 20.1 15.0 4.0 15.3 3.8
OPERATING INCOME
Operating Expenses 39.3 47.5 64.6 61.7 61.4 51.5 33.9 31.9 32.9 26.2 14.6 11.6 9.9
Selling, General and Administrative Expenses 19.2 19.1 17.1 16.7 14.4 11.4 9.8 8.7 7.8 6.6 2.9 2.2 2.1
Research and Development Expenses 20.1 28.4 47.5 44.9 47.0 40.1 24.1 23.3 25.1 19.6 11.7 9.4 7.8
Operating Income (39.3) (47.4) (63.4) (51.5) (61.4) (51.5) (33.9) (31.9) (12.8) (11.1) (10.6) 3.7 (6.1)
PRE-TAX INCOME
Interest Income Expense 0 46.6 0 0 0 0 0 0 0 18 K 0.9 0 0
Total Other Income 2.4 0.7 19.8 K 0.5 3.5 3.2 0.7 0.1 15.3 K 18 K 894 21 K 28.4 K
Pre-Tax Income (36.9) (46.7) (63.4) (51.0) (57.9) (48.3) (33.3) (31.8) (12.8) (11.1) (10.6) 3.7 (6.1)
NET INCOME
Tax Provision 637 46.6 (0.3) (0.8) (3.8) 3.2 0 (0.2) (0.2) (0.2) 894 21 K 8.39 K
Net Income (36.9) (93.3) (63.1) (50.3) (54.1) (48.3) (33.3) (31.8) (12.8) (11.1) (10.6) 3.7 (6.1)
EPS 0.58 1.78 1.23 1.1 1.25 1.18 1.13 1.5 0.67 0.6 8.87 3.06 5.11